ITeos Therapeutics Inc

NASDAQ:ITOS   3:59:52 PM EDT
28.20
+0.74 (+2.70%)
Earnings Announcements

iTeos Reports Q2 Loss Per Share Of $0.75

Published: 08/12/2021 11:35 GMT
ITeos Therapeutics Inc (ITOS) - Iteos Reports Second Quarter 2021 Financial Results and Provides Business Update.
Q2 Loss per Share $0.75.
Q2 Earnings per Share Estimate $-0.41 -- Refinitiv Ibes Data (analyst estimates).
Had Cash and Cash Equivalents of $302.9 Million As of June 30, 2021, Compared to $136.9 Million As of June 30, 2020.
Iteos Therapeutics - Believes Existing Cash, Cash Equivalents Would Enable Co to Fund Operating Expenses, Capital Expenditure Requirements Into 2026.
Revenue is expected to be $6.5 Million
Adjusted EPS is expected to be -$0.53

Next Quarter Revenue Guidance is expected to be $6.9 Million
Next Quarter EPS Guidance is expected to be -$0.60

More details on our Analysts Page.